These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6312795)

  • 1. Successful management of severe congestive cardiac failure with enalapril.
    Dickstein K; Gundersen T
    Am J Med; 1983 Oct; 75(4):721-3. PubMed ID: 6312795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic hemodynamic effects of enalapril (MK-421) in congestive heart failure.
    Dickstein K; Søyland E; Gundersen T; Abrahamsen AM; Kjekshus J
    Int J Cardiol; 1984 Oct; 6(4):445-58. PubMed ID: 6092286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and hemodynamic experience with enalapril in congestive heart failure.
    Cody RJ
    Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure.
    Dunkman WB; Wilen M; Franciosa JA
    Chest; 1983 Nov; 84(5):539-45. PubMed ID: 6313304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
    Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN
    Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
    Lantz P; Enghoff E; Hedlund A; Hägg A
    Scand J Urol Nephrol Suppl; 1984; 79():129-32. PubMed ID: 6089312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long-term response to enalapril in congestive failure.
    Kjekshus JK; Søyland E; Dickstein K; Abrahamsen AM; Gundersen T
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6099734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalapril for severe congestive heart failure. A double-blind study.
    Jennings G; Kiat H; Nelson L; Kelly MJ; Kalff V; Johns J
    Med J Aust; 1984 Nov; 141(11):723-6. PubMed ID: 6094995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
    Cody RJ; Covit AB; Schaer GL; Laragh JH
    J Am Coll Cardiol; 1983 Apr; 1(4):1154-9. PubMed ID: 6187789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure.
    Franciosa JA; Wilen MM; Jordan RA
    J Am Coll Cardiol; 1985 Jan; 5(1):101-7. PubMed ID: 2981088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril in heart failure.
    Nicholls MG; Ikram H; Espiner EA; Webster MW; Fitzpatrick MA
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):163S-167S. PubMed ID: 6099733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II-mediated vasoconstriction in chronic congestive heart failure, and response to converting enzyme inhibition.
    Cody RJ
    Am J Med; 1984 Aug; 77(2A):71-7. PubMed ID: 6089559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate converting-enzyme inhibition with intravenous enalapril in chronic congestive heart failure.
    Kubo SH; Cody RJ; Laragh JH; Prida XE; Atlas SA; Yuan Z; Sealey JE
    Am J Cardiol; 1985 Jan; 55(1):122-6. PubMed ID: 2981462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure.
    Creager MA; Massie BM; Faxon DP; Friedman SD; Kramer BL; Weiner DA; Ryan TJ; Topic N; Melidossian CD
    J Am Coll Cardiol; 1985 Jul; 6(1):163-73. PubMed ID: 2989349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.
    Sharpe DN; Murphy J; Coxon R; Hannan SF
    Circulation; 1984 Aug; 70(2):271-8. PubMed ID: 6329547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.
    Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
    Br Heart J; 1983 Aug; 50(2):163-9. PubMed ID: 6309203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril.
    Riley LJ; Vlasses PH; Ferguson RK
    Am Heart J; 1985 May; 109(5 Pt 1):1085-9. PubMed ID: 2986440
    [No Abstract]   [Full Text] [Related]  

  • 20. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.